治疗性蛋白的递送。
Delivery of therapeutic proteins.
机构信息
Department of Pharmaceutical Sciences, 521 Hochstetter Hall, University at Buffalo, The State University of New York, Amherst, New York 14260, USA.
出版信息
J Pharm Sci. 2010 Jun;99(6):2557-75. doi: 10.1002/jps.22054.
Abstract
The safety and efficacy of protein therapeutics are limited by three interrelated pharmaceutical issues, in vitro and in vivo instability, immunogenicity and shorter half-lives. Novel drug modifications for overcoming these issues are under investigation and include covalent attachment of poly(ethylene glycol) (PEG), polysialic acid, or glycolic acid, as well as developing new formulations containing nanoparticulate or colloidal systems (e.g., liposomes, polymeric microspheres, polymeric nanoparticles). Such strategies have the potential to develop as next generation protein therapeutics. This review includes a general discussion on these delivery approaches.
摘要
蛋白质治疗药物的安全性和疗效受到三个相互关联的药物问题的限制，即体外和体内不稳定性、免疫原性和半衰期较短。为克服这些问题，正在研究新型药物修饰方法，包括聚（乙二醇）（PEG）、唾液酸多糖或乙醇酸的共价连接，以及开发包含纳米颗粒或胶体系统（例如脂质体、聚合物微球、聚合物纳米颗粒）的新配方。这些策略有可能开发成为下一代蛋白质治疗药物。本文综述了这些递药方法。
相似文献
1
Delivery of therapeutic proteins.治疗性蛋白的递送。
J Pharm Sci. 2010 Jun;99(6):2557-75. doi: 10.1002/jps.22054.
2
Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.脂质-聚合物杂化纳米颗粒作为新一代治疗性递送平台：综述
Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):427-43. doi: 10.1016/j.ejpb.2013.07.002. Epub 2013 Jul 17.
3
5-Fluorouracil-loaded PLA/PLGA PEG-PPG-PEG polymeric nanoparticles: formulation, in vitro characterization and cell culture studies.载 5-氟尿嘧啶的 PLA/PLGA-PEG-PPG-PEG 嵌段共聚物纳米粒的制备、体外评价及细胞培养研究。
Drug Dev Ind Pharm. 2014 Apr;40(4):560-7. doi: 10.3109/03639045.2013.775581. Epub 2013 Apr 18.
4
Preferential tumor accumulation and desirable interstitial penetration of poly(lactic-co-glycolic acid) nanoparticles with dual coating of chitosan oligosaccharide and polyethylene glycol-poly(D,L-lactic acid).具有壳寡糖和聚乙二醇-聚（D，L-乳酸）双重涂层的聚（乳酸-共-乙醇酸）纳米颗粒在肿瘤中的优先积累和良好的间质渗透。
Acta Biomater. 2016 Jan;29:248-260. doi: 10.1016/j.actbio.2015.10.017. Epub 2015 Oct 22.
5
Effect of the molecular weight of poly(ethylene glycol) used as emulsifier on alpha-chymotrypsin stability upon encapsulation in PLGA microspheres.用作乳化剂的聚乙二醇分子量对α-糜蛋白酶包封于聚乳酸-羟基乙酸共聚物微球中的稳定性的影响
J Pharm Pharmacol. 2005 Oct;57(10):1261-69. doi: 10.1211/jpp.57.10.0004.
6
Effect of the covalent modification with poly(ethylene glycol) on alpha-chymotrypsin stability upon encapsulation in poly(lactic-co-glycolic) microspheres.聚乙二醇共价修饰对α-糜蛋白酶包封于聚乳酸-乙醇酸共聚物微球中的稳定性的影响。
J Pharm Sci. 2005 Feb;94(2):327-40. doi: 10.1002/jps.20243.
7
Poly(ethylene glycol)-modified proteins: implications for poly(lactide-co-glycolide)-based microsphere delivery.聚乙二醇修饰的蛋白质：对基于聚丙交酯-乙交酯的微球递送的影响
AAPS J. 2009 Mar;11(1):88-98. doi: 10.1208/s12248-009-9081-8. Epub 2009 Feb 6.
8
The In Vivo Pharmacokinetics of Block Copolymers Containing Polyethylene Glycol Used in Nanocarrier Drug Delivery Systems.用于纳米载体药物递送系统的含聚乙二醇嵌段共聚物的体内药代动力学。
Drug Metab Dispos. 2022 Jun;50(6):827-836. doi: 10.1124/dmd.121.000568. Epub 2022 Jan 22.
9
Nanoparticles Based on Novel Carbohydrate-Functionalized Polymers.基于新型糖基功能化聚合物的纳米粒子。
Molecules. 2020 Apr 10;25(7):1744. doi: 10.3390/molecules25071744.
10
Nanosized Delivery Systems for Therapeutic Proteins: Clinically Validated Technologies and Advanced Development Strategies.用于治疗性蛋白质的纳米级递送系统：临床验证技术与先进开发策略
Front Bioeng Biotechnol. 2020 Feb 14;8:89. doi: 10.3389/fbioe.2020.00089. eCollection 2020.
引用本文的文献
1
Comprehensive Physicochemical Characterization and in Vitro Human Cell Culture Studies of an Innovative Biocompatible and Biodegradable Silk-Derived Protein Hydrolysate, SDP-4.一种创新的生物相容性和可生物降解的丝源蛋白水解产物SDP-4的综合物理化学表征及体外人细胞培养研究
ACS Omega. 2025 Jan 14;10(3):2762-2777. doi: 10.1021/acsomega.4c08514. eCollection 2025 Jan 28.
2
An effective cell-penetrating peptide-based loading method to extracellular vesicles and enhancement in cellular delivery of drugs.一种基于细胞穿透肽的有效方法，用于将药物装载到细胞外囊泡中并增强其细胞递送能力。
Anal Bioanal Chem. 2025 Mar;417(8):1449-1459. doi: 10.1007/s00216-025-05742-1. Epub 2025 Jan 21.
3
Peptide Acylation in Aliphatic Polyesters: a Review of Mechanisms and Inhibition Strategies.脂肪族聚酯中的肽酰化：机制和抑制策略综述。
Pharm Res. 2024 Apr;41(4):765-778. doi: 10.1007/s11095-024-03682-6. Epub 2024 Mar 19.
4
Intracellular Delivery of Functional Proteins with DNA-Protein Nanogels-Lipids Complex.利用 DNA-蛋白质纳米凝胶-脂质复合物实现功能性蛋白质的细胞内递送。
J Am Chem Soc. 2024 Feb 28;146(8):5118-5127. doi: 10.1021/jacs.3c08000. Epub 2024 Feb 16.
5
Design Rules for the Sequestration of Viruses into Polypeptide Complex Coacervates.将病毒隔离到多肽复合凝聚层中的设计规则
Biomacromolecules. 2024 Feb 12;25(2):741-753. doi: 10.1021/acs.biomac.3c00938. Epub 2023 Dec 16.
6
Stabilization challenges and aggregation in protein-based therapeutics in the pharmaceutical industry.制药行业中基于蛋白质的治疗药物的稳定性挑战与聚集
RSC Adv. 2023 Dec 11;13(51):35947-35963. doi: 10.1039/d3ra06476j. eCollection 2023 Dec 8.
7
Matrixed CDR grafting: A neoclassical framework for antibody humanization and developability.基质化 CDR 嫁接：抗体人源化和可开发性的新古典框架。
J Biol Chem. 2024 Jan;300(1):105555. doi: 10.1016/j.jbc.2023.105555. Epub 2023 Dec 10.
8
Effect of IFN‑γ encapsulated liposomes on major signal transduction pathways in the lymphocytes of patients with lung cancer.γ干扰素包封脂质体对肺癌患者淋巴细胞主要信号转导通路的影响
Oncol Lett. 2023 Nov 8;27(1):8. doi: 10.3892/ol.2023.14141. eCollection 2024 Jan.
9
Smart nanoparticles for cancer therapy.智能纳米颗粒用于癌症治疗。
Signal Transduct Target Ther. 2023 Nov 3;8(1):418. doi: 10.1038/s41392-023-01642-x.
10
Enzyme Engineering Strategies for the Bioenhancement of L-Asparaginase Used as a Biopharmaceutical.酶工程策略用于增强作为生物制药的 L-天冬酰胺酶的生物利用度。
BioDrugs. 2023 Nov;37(6):793-811. doi: 10.1007/s40259-023-00622-5. Epub 2023 Sep 12.
本文引用的文献
1
PEGylation: Posttranslational bioengineering of protein biotherapeutics.聚乙二醇化：蛋白质生物治疗药物的翻译后生物工程
Drug Discov Today Technol. 2008 Autumn;5(2-3):e57-64. doi: 10.1016/j.ddtec.2009.02.002.
2
PEG conjugates in clinical development or use as anticancer agents: an overview.聚乙二醇偶联物在临床开发或用作抗癌药物方面的应用：概述。
Adv Drug Deliv Rev. 2009 Nov 12;61(13):1177-88. doi: 10.1016/j.addr.2009.02.010. Epub 2009 Aug 9.
3
Recombinant antibody therapeutics: the impact of glycosylation on mechanisms of action.重组抗体治疗药物：糖基化对作用机制的影响。
Trends Pharmacol Sci. 2009 Jul;30(7):356-62. doi: 10.1016/j.tips.2009.04.007. Epub 2009 Jun 22.
4
Effect of route of administration of human recombinant factor VIII on its immunogenicity in Hemophilia A mice.人重组因子 VIII 给药途径对血友病 A 小鼠免疫原性的影响。
J Pharm Sci. 2009 Dec;98(12):4480-4. doi: 10.1002/jps.21765.
5
Role of glycosylation in conformational stability, activity, macromolecular interaction and immunogenicity of recombinant human factor VIII.糖基化在重组人凝血因子 VIII 的构象稳定性、活性、大分子相互作用及免疫原性中的作用
AAPS J. 2009 Sep;11(3):424-31. doi: 10.1208/s12248-009-9119-y. Epub 2009 Jun 5.
6
Enhanced circulation half-life of site-specific PEGylated rhG-CSF: optimization of PEG molecular weight.位点特异性聚乙二醇化重组人粒细胞集落刺激因子的循环半衰期延长：聚乙二醇分子量的优化
J Biotechnol. 2009 Jul 15;142(3-4):259-66. doi: 10.1016/j.jbiotec.2009.05.012. Epub 2009 Jun 2.
7
Site-specific polysialylation of an antitumor single-chain Fv fragment.肿瘤靶向单链 Fv 片段的位点特异性多聚唾液酸化。
Bioconjug Chem. 2009 May 20;20(5):924-31. doi: 10.1021/bc8005122.
8
Lipid-based systemic delivery of siRNA.基于脂质的小干扰RNA全身递送
Adv Drug Deliv Rev. 2009 Jul 25;61(9):721-31. doi: 10.1016/j.addr.2009.03.003. Epub 2009 Mar 26.
9
Nanostructured lipid carrier-based hydrogel formulations for drug delivery: a comprehensive review.基于纳米结构脂质载体的水凝胶药物递送制剂：综述
Expert Opin Drug Deliv. 2009 Feb;6(2):165-76. doi: 10.1517/17425240802712590.
10
PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery.用于控释给药的聚乳酸-羟基乙酸共聚物-卵磷脂-聚乙二醇核壳纳米颗粒
Biomaterials. 2009 Mar;30(8):1627-34. doi: 10.1016/j.biomaterials.2008.12.013. Epub 2008 Dec 25.
Zotero 插件